Dobutamine-stress electrocardiographically gated positron emission tomography for detection of viable but dysfunctional myocardium

J Nucl Cardiol. 1999 Nov-Dec;6(6):626-32. doi: 10.1016/s1071-3581(99)90100-9.

Abstract

Purpose: This study was performed to determine whether low-dose dobutamine stress electrocardiography (ECG)-gated fluorine-18 fluorodeoxyglucose (FDG)-positron emission tomography (PET) can assess wall motion and identify myocardium without contractile reserve despite preserved FDG uptake.

Methods: Fifty-three patients with myocardial infarction and normal sinus rhythm underwent ECG-gated FDG-PET and transthoracic echocardiography. Wall motion of 10 segments of the left ventricle was graded as normal, hypokinetic, or akinetic/dyskinetic.

Results: In 365 (76%) of 480 segments, assessment of wall motion was concordant between the 2 modalities. In 30 patients dobutamine-stress ECG-gated FDG-PET was performed. In 13 (50%) of 26 dysfunctional segments with normal FDG uptake, 16 (36%) of 44 dysfunctional segments with mildly reduced FDG uptake and 12 (25%) of 48 dysfunctional segments with moderately reduced FDG uptake, wall motion was improved by dobutamine infusion.

Conclusion: Assessment of left ventricular wall motion with ECG-gated FDG-PET is feasible, and dobutamine stress ECG-gated FDG-PET can simultaneously identify metabolic viability and contractile reserve.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Dobutamine*
  • Echocardiography
  • Electrocardiography*
  • Feasibility Studies
  • Female
  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Heart / diagnostic imaging
  • Heart / physiopathology
  • Heart Rate / physiology
  • Humans
  • Male
  • Middle Aged
  • Myocardial Contraction / physiology*
  • Myocardial Infarction / diagnostic imaging*
  • Myocardial Infarction / metabolism
  • Myocardial Infarction / physiopathology
  • Myocardium / metabolism
  • Myocardium / pathology
  • Radiopharmaceuticals / pharmacokinetics
  • Tissue Survival
  • Tomography, Emission-Computed*
  • Vasodilator Agents*
  • Ventricular Dysfunction, Left / diagnostic imaging
  • Ventricular Dysfunction, Left / metabolism
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Function, Left / physiology

Substances

  • Radiopharmaceuticals
  • Vasodilator Agents
  • Fluorodeoxyglucose F18
  • Dobutamine